2nd Cell Therapy for Autoimmune Disease Summit
December 2-4, 2024
Philadelphia, PA
The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space.
Register now to take advantage of a 10% discount with code 47406AA: https://ter.li/a3etsk
At this year’s summit, you will:
- Discover the latest clinical results demonstrating the benefits of cell therapies for autoimmune conditions from leading organizations such as BMS, Cabaletta Bio, and Quell Therapeutics.
- Gain insights into accelerating clinical entry through preclinical findings shared by Abata Therapeutics, Intellia Therapeutics, and Cincinnati Children’s Hospital Medical Center.
- Learn how to optimize the engineering of advanced cell therapies to enhance efficacy, potency, and reliable remission, with contributions from Gentibio, Appia Bio, and Synaptimmune.
- Explore the long-term effects of cell therapies in autoimmune patients and the underlying mechanisms, presented by iCell Gene, the University of Tennessee, and UT Health San Antonio.
- Understand regulatory CMC and safety expectations for entering the autoimmune space with guidance from the Association for the Advancement of Blood & Biotherapies, Cartesian Therapeutics, and IASO Biotherapeutics.